Clinical Fellowships

Roswell Park Comprehensive Cancer Center was the first research laboratory in the world to focus exclusively on cancer. Established in 1898 by eminent American surgeon Dr. Roswell Park, it expanded in 1913 with the opening of a cancer hospital. By uniting research and clinical care, the Institute became a model for speeding the transfer of knowledge from the laboratory to the patient’s bedside.

Ready to Apply?

Download Clinical Fellowship application.

Download Now

Today Roswell Park is a freestanding cancer center that employs more than 3,200 people, including 299 faculty members whose work encompasses patient care, research, and education. The Institute is one of only 51 National Cancer Institute-designated comprehensive cancer centers in the nation. Roswell Park is also a member of the National Comprehensive Cancer Network (NCCN), an alliance of leading cancer centers that work together toward continuous quality improvement and the creation of evidence-based practice guidelines.

Among other distinctions:

  • We are home to one of the largest early-phase clinical trials programs
  • Roswell Park provides advanced training in robot-assisted surgery for hundreds of surgeons from all over the world.
  • The Institute is set in the heart of the Buffalo Niagara Medical Campus (BNMC), placing physicians in an exciting environment that encourages and supports collaboration and innovation in clinical care and research. Roswell Park is just steps away from the new John R. Oishei Children’s Hospital and the Jacobs School of Medicine and Biomedical Sciences of the University at Buffalo, both opening in 2017, as well as the Hauptman-Woodward Medical Research Institute and the New York State Center of Excellence in Bioinformatics and Life Sciences. The BNMC is a rapidly evolving incubator for biotech start-ups.
  • Roswell Park’s Center for Immunotherapy is equipped with a cGMP Therapeutic Cell Production Facility, Immune Analysis Facility, and Vector Development & Production Facility, and is capable of taking a drug from development to clinical trials all in one location.
  • Roswell Park developed the prostate-specific antigen (PSA) test and photodynamic therapy (PDT), and made significant contributions to the Human Genome Project.

In every aspect of our operations, we’re guided by the Roswell Park mission: to understand, prevent, and cure cancer.

Advanced Training in Clinical Oncology & Oncologic Research

Fellows at Roswell Park complete one or more years in advanced clinical training programs, during which time they may also conduct clinical and basic research in their areas of specialization under the supervision of senior staff. Fellows also receive didactic training in clinical research and the oncological sciences.

Fellowship training is offered in several clinical areas, including:

Specialized Treatments and Therapies

The clinical case mix at Roswell Park is varied, with site-specific data for 30 cancer sites recorded each year. Patients have access to a full range of diagnostic and treatment services, including therapies not available elsewhere in the region.

Specialized treatments include:

  • Blood and Marrow Transplantation
  • Robot-Assisted Surgery
  • Immunotherapy
  • Photodynamic Therapy
  • Gamma Knife® Radiosurgery
  • Dental & Maxillofacial Care
  • Interventional Pulmonology
  • Interventional Radiology
  • Nuclear Medicine
  • High-Dose Chemotherapy

A Focus on Translational Research

Through research, clinical fellows at Roswell Park become partners in elevating the standard of oncology care. Our clinical fellows enjoy caseloads that allow the time and opportunity to pursue clinical or basic research, attend seminars, study, and write papers. Close interaction with basic scientists provides fertile ground for engaging in basic, applied, and clinical research.

The Institute’s 20 world-class shared resources include flow cytometry, small-molecule screening, translational imaging, and the Data Bank and BioRepository, which prospectively collects and provides de-identified biospecimens and associated epidemiological and clinical data to investigators with IRB-approved protocols.